Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 6:46:27-34.
doi: 10.1016/j.athplu.2021.11.001. eCollection 2021 Dec.

Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes

Affiliations

Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes

Mikio Marumo et al. Atheroscler Plus. .

Abstract

Background and aims: We have recently proposed urinary pteridine level as a useful biomarker of oxidative stress in a general population. However, the significance of urinary pteridines in patients with diabetes is unknown.

Methods: The relationships of the level of urinary pteridine derivatives with d-dimer, ankle-brachial pressure index (ABI), and known cardiovascular risk factors were investigated in patients with type 2 diabetes.

Results: Urinary pteridine level showed significant positive correlations with urinary15-isoprostane F2t, female gender, history of smoking and d-dimer and significant inverse correlations with history of alcohol drinking, body mass index (BMI) and ABI. ABI was significantly lower and d-dimer was significantly higher in the highest tertile group of pteridines than in the lowest tertile group. The odds ratios of the highest vs. lowest tertiles for low ABI and high d-dimer were significantly higher than the reference level. The above relationships of urinary pteridines with ABI and d-dimer were not altered when age, gender, BMI, hemoglobin A1c and history of alcohol drinking were used as explanatory variables in multivariable analyses. History of smoking confounded the relation of pteridines with ABI but not that with d-dimer. However, in logistic regression analysis, the association between pteridines and ABI remained significant with adjustment for history of smoking.

Conclusion: Urinary pteridine level was associated with d-dimer and ABI, which reflect blood coagulability and arterial flow to the lower extremities, respectively, and is thus thought to be a useful discriminator of thromboatherosclerotic risk in patients with diabetes.

Keywords: Blood coagulation; Diabetes; Oxidative stress; Peripheral arterial disease; Pteridines.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Histograms of urinary pteridines (A) and log-transformed pteridines (B).
Fig. 2
Fig. 2
Correlations of log-transformed pteridines with log-transformed 15-isoprostane F2t (A) and urinary creatinine (B). Pearson's correlation coefficients are given in the figures. Asterisks denote significant correlations (∗∗, p < 0.01).
Fig. 3
Fig. 3
Comparison of mean levels of ABI (A) and log-transformed d-dimer (B) in the tertile groups of urinary pteridines. In multivariable analysis, age, gender, BMI, hemoglobin A1c and history of alcohol drinking were adjusted (Multivariable analysis 1 and 2). In addition, history of smoking was adjusted in Multivariable analysis 2. Asterisks denote significant differences from the 1st tertile for pteridine (∗, p < 0.05; ∗∗, p < 0.01). #, a marginally significant difference from the 1st tertile for pteridine (p = 0.077).
Fig. 4
Fig. 4
ROC curves for urinary pteridine level to predict low ABI and high d-dimer. Cutoff points of urinary pteridine level, yielding maximal sensitivity plus specificity for predicting low ABI and high d-dimer, in the ROC curves were determined. The value with arrow, indicating the cutoff points in the figures, are cut-off values. Specificity and sensitivity of the cutoffs were 66.4% and 84.2%, respectively.

References

    1. Gu K., Cowie C.C., Harris M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21:1138–1145. - PubMed
    1. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., et al. Emerging Risk Factors Collaboration, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222. - PMC - PubMed
    1. Virmani R., Burke A.P., Kolodgie F. Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol. 2006;22(Suppl B):81B–84B. - PMC - PubMed
    1. Gao X., Song J., Watase H., Hippe D.S., Zhao X., et al. Differences in carotid plaques between symptomatic patients with and without diabetes mellitus. Arterioscler Thromb Vasc Biol. 2019;39:1234–1239. CARE-II Investigators. - PubMed
    1. Low Wang C.C., Hess C.N., Hiatt W.R., Goldfine A.B. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in Type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133:2459–2502. - PMC - PubMed

LinkOut - more resources